AIP
VIVE

Ameritas Investment Partners’s VIVEVE MED INC VIVE Stock Holding History

Ameritas Investment Partners’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1
Closed -$5K – 3082
2018
Q1 		$5K Hold
1
– – ﹤0.01% 2867
2017
Q4 		$7K Hold
1
– – ﹤0.01% 2834
2017
Q3 		$7K Hold
1
– – ﹤0.01% 2877
2017
Q2 		$9K Buy
+1
New +$7.45K ﹤0.01% 2850

Other funds holding VIVE

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Ameritas Investment Partners's VIVE Position: Q2 2018 in Review

Ameritas Investment Partners sold out of VIVEVE MED INC (VIVE) in Q2 2018, closing a stake of 1 share — an estimated $5K sold.

Ameritas Investment Partners first reported a position in VIVE in Q2 2017 and held it in 4 quarters. The position peaked at $9K in Q2 2017. 46 funds tracked by Wall St. Rank hold VIVE as of Q2 2018.

  • Ameritas Investment Partners reported no remaining VIVEVE MED INC position as of Q2 2018 after selling out during the quarter.
  • Ameritas Investment Partners sold 1 VIVEVE MED INC share in Q2 2018, an estimated $5K.
  • Ameritas Investment Partners first reported a position in VIVEVE MED INC in Q2 2017 and held it in 4 quarters.
  • Ameritas Investment Partners's VIVEVE MED INC position peaked at $9K in Q2 2017.
  • 46 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q2 2018.

Based on Ameritas Investment Partners's 13F filing for Q2 2018, filed 13 Aug 2018.